Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Systemic Lidocaine Infusion for Pain Control in Ventral Hernia
NCT03484650Phase 3Withdrawn
- Sponsor
- Carilion Clinic
- Start
- Jan 2020
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of Lidocaine Hydrochloride Injection, without epinephrine in postoperative pain, sponsored by Carilion Clinic. Planned start Jan 2020; status: withdrawn.
02
Drugs
Lidocaine Hydrochloride Injection, without epinephrine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT03484650.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03484650.